PharmAthene to Present on Wednesday, November 12th at the 10th Annual Rodman & Renshaw Healthcare Conference
ANNAPOLIS, Md., Nov. 4 /PRNewswire-FirstCall/ -- PharmAthene, Inc.,
(NYSE Alternext US: PIP) a biodefense company developing medical
countermeasures against biological and chemical threats, announced today that
David P. Wright, President and Chief Executive Officer of PharmAthene, will
present at the Rodman and Renshaw 10th Annual Healthcare Conference in New
York on Wednesday, November 12, 2008 beginning at 2:25 p.m. E.T. in the Holmes
II Room (4th Floor) at The New York Palace Hotel.
PharmAthene's presentation will be available via webcast on the company's
website at http://www.pharmathene.com. To access the webcast go to the
Investor Relations page and click on the links Calendar of Events /
PharmAthene at Rodman & Renshaw Healthcare Conference. For assistance contact
Stacey Jurchison at 410-269-2610.
About PharmAthene, Inc.
PharmAthene was formed to meet the critical needs of the United States and
its allies by developing and commercializing medical countermeasures against
biological and chemical weapons. PharmAthene's lead product development
programs include:
-- SparVax(TM) - a second generation recombinant protective antigen (rPA)
anthrax vaccine
-- Third generation rPA anthrax vaccine
-- Valortim(R) - a fully human monoclonal antibody for the prevention and
treatment of anthrax infection
-- Protexia(R) - a novel bioscavenger for the prevention and treatment of
morbidity and mortality associated with exposure to chemical nerve
agents
-- RypVax(TM) - a recombinant dual antigen vaccine for plague
